As shown in Fig. 1B, similar to treated tumor cell lines, topotecan treatment induced dephosphorylation of rpS6 regardless of the p53 status of the xenografts, whereas 4E-BP1 dephosphorylation occurred only in the presence of functional p53. The gene discussed is RPS6; the disease is neoplasm.